Introduction {#s1}
============

Surface proteins of *Staphylococcus aureus* and other gram-positive cocci enter the secretory pathway with their N-terminal signal peptides ([@bib12]). Once translocated across the membrane, surface proteins are covalently linked to cell wall peptidoglycan via sortase A-catalyzed cleavage at the LPXTG motif of C-terminal sorting signals ([@bib55]; [@bib52]; [@bib32]). Some, but not all surface proteins are secreted at septal membranes and incorporated into cross-wall peptidoglycan ([@bib11]; [@bib8]; [@bib12]). Following division and separation of spherical daughter cells, cross-wall anchored surface proteins are displayed over large segments of the bacterial surface ([@bib13]). Cross-wall trafficking of surface proteins requires a signal peptide with YSIRK/GXXS motif ([@bib8]; [@bib12]). The YSIRK/GXXS motif is positioned N-terminal of the hydrophobic core, common to all signal peptide precursors traveling the Sec pathway ([@bib15]; [@bib14]; [@bib70]).

Gram-positive bacteria rely on cell wall-anchored surface proteins for adherence to host tissues, evasion from host immune responses and acquisition of host-specific nutrients ([@bib17]). Surface proteins with YSIRK/GXXS signal peptides are produced with high abundance and fulfill essential virulence functions during infection. For example, staphylococcal protein A (SpA) is well known for its attribute of binding to host immunoglobulin and disrupting adaptive immune responses ([@bib16]; [@bib26]). SpA is synthesized as a precursor with an N-terminal YSIRK/GXXS signal peptide and a C-terminal LPXTG motif sorting signal ([@bib1]; [@bib55]). After initiation into the secretion pathway, the signal peptide is cleaved by signal peptidase ([@bib1]; [@bib51]). Sortase A recognizes the LPXTG motif of the sorting signal, cleaves the polypeptide between the threonine (T) and the glycine (G) of the LPXTG motif and forms an acyl-enzyme intermediate with the C-terminal threonine ([@bib32]; [@bib61]). The acyl-enzyme is resolved by the nucleophilic attack of the amino-group of the pentaglycine crossbridge within lipid II, the precursor for peptidoglycan synthesis ([@bib62]; [@bib38]). The product of this reaction, surface protein linked to lipid II, is then incorporated into peptidoglycan via the transglycosylation and transpeptidation reactions of cell wall synthesis ([@bib60]; [@bib63]).

Newly synthesized SpA is secreted into the cross-wall compartment, bounded by septal membranes of burgeoning cells during division ([@bib13]). Upon completion of peptidoglycan synthesis within the cross-wall, its peptidoglycan layer is split ([@bib18]). The adjacent cells separate and assume a spherical shape, resulting in SpA display on the bacterial surface ([@bib13]). Staphylococci divide perpendicular to previous cell division planes ([@bib68]). By incorporating secreted polypeptides into newly synthesized cross-walls, staphylococci distribute SpA and other sortase A-anchored products over the bacterial surface ([@bib12]). However, not all sortase-anchored products traffic to septal membranes. Those that are secreted at polar membranes are also anchored to peptidoglycan but are not distributed over the bacterial surface ([@bib12]). In *S. aureus* strain Newman, thirteen different sortase-anchored surface proteins and four additional proteins are endowed with YSIRK/GXXS signal peptides for septal secretion: lipase (Lip), glycerol-ester hydrolase (Geh), murein hydrolase LytN and the cell size determinant Ebh ([@bib71]; [@bib18]; [@bib10]).

The mechanisms supporting YSIRK/GXXS precursor secretion at septal membranes are not known. Here we show that the signal peptide of SpA is cleaved at the YSIRK/GXXS motif. Amino acid substitutions in the SpA signal peptide that affect cleavage at the YSIRK/GXXS motif also impair septal secretion. When used as bait for the isolation of the secretion machinery, SpA Ser^18^Leu (S18L) precursor co-purified with SecA, SecDF and LtaS. We studied the contribution of these factors towards protein A secretion into the cross-wall compartment.

Results {#s2}
=======

SpA signal peptide variants {#s2-1}
---------------------------

To facilitate the analysis of signal peptide mutants, we generated SpA~ED~, a variant of protein A that is truncated for its C-terminal immunoglobulin binding domains, region X (Xr) and the LPXTG sorting signal ([Figure 1a](#fig1){ref-type="fig"}). *S. aureus* WY110 (Δ*spa*Δ*sbi*, pSpA~ED~) cultures expressing *spa~ED~* were fractionated into culture supernatant (S) and bacterial pellet (P) and analyzed by immunoblotting. SpA~ED~ was found in the extracellular medium; its precursor species was detected in the bacterial pellet ([Figure 1bc](#fig1){ref-type="fig"}). Site-directed mutagenesis was used to generate short deletions and amino acid substitutions in the signal peptide of SpA~ED~ ([Figure 1b](#fig1){ref-type="fig"}). Deletion of the YSIRK motif (ΔYSIRK) diminished the abundance of the SpA~ED/ΔYSIRK~ precursor and its processing ([Figure 1b](#fig1){ref-type="fig"}). Single amino acid substitutions at two positions in the YSIRK motif (I9S and R10A) resulted in precursor accumulation ([Figure 1b](#fig1){ref-type="fig"}). Further, the R10A variant exhibited diminished secretion and accumulated a precursor species that migrated faster on SDS-PAGE than the full-length precursor ([Figure 1bc](#fig1){ref-type="fig"}). Amino acid substitution at lysine 11 (K11A) of the YSIRK motif had no effect on SpA~ED/K11A~ precursor processing and secretion ([Figure 1bc](#fig1){ref-type="fig"}). Deletion of GIAS (ΔGIAS) or of the two variable residues in the GXXS motif (ΔIA) caused precursor accumulation and blocked precursor processing ([Figure 1bc](#fig1){ref-type="fig"}). Substitution of glycine 15 (G15L) reduced the abundance of SpA~ED/G15L~ and led to the accumulation of a unique precursor species that migrated faster on SDS-PAGE than full-length precursor ([Figure 1b](#fig1){ref-type="fig"}). Substitution of serine 18 (S18L) caused accumulation of full-length and processed precursors as well as reduced secretion ([Figure 1bc](#fig1){ref-type="fig"}).

![Mutagenesis of the signal peptide of staphylococcal protein A (SpA).\
(**a**) Schematic illustrating the primary structure of SpA and of SpA~ED~ with the immunoglobulin binding domains (IgBDs, designated E, A, B, C and D), region X (Xr), LysM domain and LPXTG sorting signal. Cleavage sites for signal peptidase and sortase A are indicated. The amino acid sequence of the SpA signal peptide is displayed. YSIRK/GXXS motif residues are printed in red. (**b**) The structural genes for SpA~ED~ and its variants were cloned into pOS1, expressed from the *spa* promoter in *S. aureus* WY110 (∆*spa* ∆*sbi*) and secretion of SpA~ED~ was analyzed by immunoblotting with SpA-specific antibody in culture supernatant (S) and lysostaphin-digested bacterial pellet (P) samples. Signal peptide bearing SpA~ED~ precursors are labeled 'Pre' on the side of each blot; 'Mat' denotes mature protein without signal peptide. The calculated molecular weight (MW) of the variant precursors are: SpA~ED,~ 16.78 kD; SpA~ED/ΔYSIRK~,16.13 kD; SpA~ED/ΔGIAS~, 16.45 kD; SpA~ED/ΔIA~, 16.59 kD; SpA~ED/ΔG15,~ 16.72 kD; SpA~ED/ΔS18,~ 16.69 kD; SpA~ED/ΔG15ΔS18,~ 16.63 kD; SpA~ED/Y7A,~ 16.68 kD; SpA~ED/I9S,~ 16.75 kD; SpA~ED/R10A,~ 16.69 kD; SpA~ED/K11A,~ 16.72 kD; SpA~ED/G15L,~ 16.83 kD; SpA~ED/S18L,~ 16.8 kD; SpA~ED/G15L/S18L,~ 16.86 kD. The MW of SpA~ED~ mature protein is 13.15 kD. Sortase A (SrtA, MW 23.54 kD) immunoblot serves as loading control. (**c**) Percent secretion of wild-type SpA~ED~ and its variants was quantified from triplicate experiments as the intensity of immunoblotting signals in the supernatant (S) divided by the sum signals in (S + P) fractions × 100. Statistical significance was analyzed with one-way ANOVA comparing each variant with wild-type and *p* values were recorded: WT vs. ∆GIAS, p=0.031; WT vs. ∆IA, p=0.0032; WT vs. R10A, p=0.0116; WT vs. S18L, p=0.0172. \* denotes p\<0.05, \*\* denotes p\<0.01.](elife-34092-fig1){#fig1}

*S. aureus* WY110 cultures were fractionated into culture supernatant (S), cell wall extract (W), membranes (M) and cytoplasm (C). The SpA~ED~ precursor was found in the cytoplasm and membrane, whereas mature product was secreted into the culture supernatant (S) ([Figure 2a](#fig2){ref-type="fig"}). Precursors of the SpA~ED/ΔIA~ and SpA~ED/R10A~ variants accumulated mostly in the cytoplasm, whereas the SpA~ED/S18L~ precursor was located predominantly in the membrane ([Figure 2ab](#fig2){ref-type="fig"}). Pulse-labeling experiments revealed that wild-type SpA~ED~ precursor was processed within 60 s into mature, secreted product ([Figure 2c](#fig2){ref-type="fig"}). In contrast, processing of the SpA~ED/ΔIA~, SpA~ED/R10A~ and SpA~ED/S18L~ precursors was delayed ([Figure 2c](#fig2){ref-type="fig"}). To test whether signal peptide variations affect trafficking of full-length SpA, mutations that encode the ΔIA, R10A and S18L amino acid changes were introduced into wild-type *spa*. Wild-type and mutant staphylococci were treated with trypsin to remove all surface proteins from the bacterial surface and incubated for 20 min to allow for cell wall deposition of newly synthesized SpA. To localize SpA, bacteria were viewed by fluorescence microscopy after labeling with SpA-specific monoclonal antibody and Alexa Fluor 647-conjugated secondary IgG (red) and with BODIPY FL-vancomycin (green), which binds to cell wall peptidoglycan. As expected, wild-type SpA was assembled in the cross-wall compartment, whereas SpA~SP-SasF~, a protein A variant that is secreted via a canonical (non-YSIRK/GXXS) signal peptide, was deposited into peripheral segments of the cell wall envelope ([@bib12])([Figure 2d](#fig2){ref-type="fig"}). SpA~ΔIA~, SpA~R10A~ and SpA~S18L~ exhibited defects in surface display, consistent with their observed defects in precursor processing and secretion ([Figure 2d](#fig2){ref-type="fig"}). Residual amounts of cross-wall localization were observed for SpA~R10A~ and SpA~S18L~, whereas SpA~ΔIA~ was not detected in the cross-wall compartment ([Figure 2e](#fig2){ref-type="fig"}). Together these data indicate that some features of the YSIRK/GXXS motif, specifically Arg^10^, Ser^18^ and the GXXS motif, are crucial for septal secretion of SpA in *S. aureus* ([Figure 2e](#fig2){ref-type="fig"}).

![SpA signal peptide variants defective in precursor processing and septal secretion.\
(**a**) *S. aureus* cultures were fractionated into cytoplasm (C), membrane (M), cell wall (W) and culture supernatant (S) and analyzed by immunoblotting with αSpA to reveal the subcellular location of wild-type SpA~ED~ precursor and secreted product of the SpA~ED/ΔIA~, SpA~ED/S18L~, and SpA~ED/R10A~ variants. Immunoblotting with αSrtA and αL6 was used to establish fractionation and loading controls. (**b**) Quantification of immunoblot signal intensity in (**a**) using Image J. Precursor abundance (%) the bacterial cytoplasm (C) and membrane (M) was quantified from triplicate experiments as the intensity of immunoblotting signals divided by the sum signals in all four fractions (C + M + W + S)×100. Statistical significance was analyzed with one-way ANOVA comparing each variant with wild-type and *p* values were recorded: for \[C/(C + M + W + S)\]×100, WT vs. ∆IA, p\<0.0001; WT vs. S18L, p=0.0042; WT vs. R10A, p\<0.0001; for \[M/(C + M + W + S)\]×100, WT vs. ∆IA, p=0.0056; WT vs. S18L, p\<0.0001; WT vs. R10A, p=0.0405. \*\*\*\* denotes p\<0.0001, \*\* denotes p\<0.01, \* denotes p\<0.05. (**c**) *S. aureus* cultures were pulse-labeled for 60 s with \[^35^S\]methionine and labeling quenched by adding an excess of non-radioactive methionine (chase). At timed intervals during the pulse (0') or 1 (1'), 5 (5'), and 20 (20') minutes after the pulse (chase), culture aliquots were precipitated with trichloroacetic acid (TCA), lysostaphin-treated, immunoprecipitated with αSpA and analyzed by autoradiography. (**d**) *S. aureus* WY110 (∆*spa* ∆*sbi*) harboring chromosomal pCL55-insertions of wild-type *spa* (SpA), *spa~ΔIA~* (SpA~ΔIA~) *spa~S18L~* (SpA~S18L~), *spa~R10A~* (SpA~R10A~) *spa~SP-SasF~* (SpA~SP-SasF~) or pCL55 alone (Vector) were treated with trypsin to remove SpA. Bacteria were incubated for 20 min to allow for secretion and cell wall deposition of newly synthesized SpA. Samples were incubated with BODIPY-FL vancomycin (Vancomycin) (green) to stain the bacterial cell wall and with SpA-specific monoclonal antibody and Alexa fluor 647-labeled secondary IgG (red) to reveal SpA. (**e**) SpA-positive staphylococci in images derived from samples in (**d**) were analyzed for SpA deposition at the cross wall of diplococci (n = 200). Data from three independent experiments were used to derive the mean (± SEM) and were analyzed for significant differences with one-way ANOVA for comparisons between wild-type and mutant SpA. *p* values were recorded: SpA vs. SpA~∆IA~, p\<0.0001; SpA vs. SpA~S18L~, p=0.0006; SpA vs. SpA~R10A~, p=0.0004; SpA vs. SpA~SP-SasF~, p\<0.0001; SpA vs. Vector, p\<0.0001. \*\*\*\* denotes p\<0.0001, \*\*\* denotes p\<0.001.](elife-34092-fig2){#fig2}

Processing of SpA signal peptide variants {#s2-2}
-----------------------------------------

Wild-type SpA~ED~, SpA~ED/ΔIA~, SpA~ED/R10A~ and SpA~ED/S18L~ were purified from staphylococcal membranes via affinity chromatography, analyzed by Coomassie-stained SDS-PAGE and identified by Edman degradation ([Figure 3a](#fig3){ref-type="fig"}). For wild-type SpA~ED~, full-length precursor (SpA~ED~-1, starting at Met^1^), as well as two precursors with faster mobility on SDS-PAGE (SpA~ED~-2 and SpA~ED~-3) and mature product (SpA~ED~-4), that is SpsB signal peptidase-cleaved SpA~ED~ starting at Ala^37^, were identified ([Figure 3ab](#fig3){ref-type="fig"}). Edman degradation revealed that SpA~ED~-2 is a product of proteolytic cleavage within the YSIRK/GXXS motif (N-terminus Gly^13^). SpA~ED~-3 is a product of further cleavage, as Edman degradation identified its N-terminal amino acid 10 residues downstream (N-terminus Thr^23^) ([Figure 3ab](#fig3){ref-type="fig"}). Purified SpA~ED~-1 precursor as well as its SpA~ED~-2, SpA~ED~-3 and SpA~ED~-4 cleavage products were analyzed by MALDI-TOF-MS, confirming the predicted mass of the precursor and its cleaved species ([Table 1](#table1){ref-type="table"}). SDS-PAGE and Edman analysis of the SpA~ED/S18L~ sample revealed the same four species as wild-type SpA~ED~, albeit that the abundance of SpA~ED/S18L~-1 and SpA~ED/S18L~-4 was increased over that of SpA~ED/S18L~-2 and SpA~ED/S18L~-3 ([Figure 3ab](#fig3){ref-type="fig"}). Analysis of the SpA~ED/R10A~ sample also identified four species, including SpA~ED/\ R10A~-1 precursor, SpA~ED/\ R10A~-3 cleavage product (N-terminus Thr^23^) and SpA~ED/\ R10A~-4 mature product (N-terminus Ala^37^), whereas SpA~ED/\ R10A~-2 represented a variant cleavage product (N-terminus Ala^10^) ([Figure 3ab](#fig3){ref-type="fig"}). The SpA~ED/ΔIA~ sample yielded the same precursor and cleavage species as SpA~ED~ and SpA~ED/S18L~, however the abundance of SpA~ED/ΔIA~-1 was increased over that of SpA~ED/ΔIA~-2, SpA~ED/ΔIA~-3 and SpA~ED/ΔIA~-4 ([Figure 3ab](#fig3){ref-type="fig"}). Taken together, these data indicate that the SpA precursor (SpA~ED~-1) is cleaved between Leu^12^ and Gly^13^, which are positioned between the two motifs (underlined) of the [YSIRK]{.ul}L/GV[GIAS]{.ul} sequence. The R10A substitution alters the cleavage site and diminishes precursor cleavage, whereas the S18L substitution and ΔIA deletion diminish precursor cleavage without altering the cleavage site between the YSIRK/GXXS motifs. Precursor cleavage between Gly^22^ and Thr^23^ was observed for all SpA variants, suggesting that it represents a proteolytic event unrelated to the function of the YSIRK/GXXS motif in targeting SpA secretion to septal membranes.

![Proteolytic cleavage of the SpA signal peptide.\
(**a**) Wild-type SpA~ED~ or SpA~ED/ΔIA~, SpA~ED/S18L~, and SpA~ED/R10A~ variant precursors and cleavage products were purified from detergent-solubilized staphylococcal membranes using affinity chromatography on IgG-sepharose and analyzed on Coomassie-Blue stained SDS-PAGE. Full length precursors (1) and their cleavage products (2-4) were analyzed by Edman degradation and MALDI-TOF mass spectrometry. See [Table 1](#table1){ref-type="table"} for mass spectrometry data. (**b**) Schematic illustrating the proteolytic cleavage sites for each of the four precursors SpA~ED~, SpA~ED/ΔIA~, SpA~ED/S18L~ and SpA~ED/R10A~.](elife-34092-fig3){#fig3}
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###### MALDI-TOF-MS ion signals of purified SpA~ED~ species and their variants

  Protein          Observed *m/z*   Calculated *m/z*\*   ∆obs.- calc.
  ---------------- ---------------- -------------------- --------------
  SpA~ED~-1        16776.47         16777.7              1.23
  SpA~ED~-2        15273.92         15273.78             0.14
  SpA~ED~-3        14418.92         14418.78             0.14
  SpA~ED~-4        13152.40         13152.32             0.08
  SpA~ED/S18L~-1   16803.02         16803.78             0.76
  SpA~ED/S18L~-2   15298.89         15299.86             0.97
  SpA~ED/S18L~-3   14417.89         14418.78             0.89
  SpA~ED/S18L~-4   13152.22         13152.32             0.10
  SpA~ED/∆IA~-1    16592.95         16593.46             0.51
  SpA~ED/∆IA~-2    15088.71         15089.54             0.83
  SpA~ED/∆IA~-3    14417.86         14418.78             0.92
  SpA~ED/∆IA~-4    13151.55         13152.32             0.77
  SpA~ED/R10A~-1   16692.99         16692.59             0.40
  SpA~ED/R10A~-2   15584.97         15586.2              1.23
  SpA~ED/R10A~-3   14418.46         14418.78             0.32
  SpA~ED/R10A~-4   13152.07         13152.32             0.25

\*Based on average mass calculated with the online ExPASy tool.

Identification of proteins that co-purify with mutant SpA precursor {#s2-3}
-------------------------------------------------------------------

We used a biochemical approach to identify staphylococcal proteins that interact with SpA precursor in septal membranes. The SpA~ED/S18L~ precursor accumulates in septal membranes ([Figure 2bc](#fig2){ref-type="fig"}) and can be purified following solubilization with detergent ([Figure 3ab](#fig3){ref-type="fig"}). After crosslinking with formaldehyde, SpA~ED/S18L~ precursor and associated species were isolated by affinity chromatography, heat-treated (95°C) to resolve crosslinks and analyzed by Coomassie-stained SDS-PAGE and immunoblotting with anti-SpA ([Figure 4ab](#fig4){ref-type="fig"}). As compared to SpA~ED/SP-SasF~, several proteins co-purified with SpA~ED/S18L~ and were identified by mass spectrometry ([Figure 4ab](#fig4){ref-type="fig"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). SecA was the most abundant protein. In *E. coli*, SecA forms a homodimer and binds signal peptide-bearing precursors for subsequent translocation through the SecYEG translocon ([@bib21]; [@bib65]). In agreement with this model, SecA co-purification with SpA~ED/S18L~, but not SpA~ED~, from staphylococcal extracts was detected by immunoblotting both in the presence and in the absence of crosslinking agent ([Figure 4c](#fig4){ref-type="fig"}). SecA also did not co-purify with formaldehyde-treated SpA~ED/SP-SasF~ ([Figure 4d](#fig4){ref-type="fig"}). Most of the proteins crosslinked to SpA~ED/S18L~ are components of the peptidoglycan (PBP2, MurE2, MurG, FemA, FemB, FemX), wall teichoic acid (TagB, TagF) and lipoteichoic acid synthesis pathways (LtaS) that are known to be localized to septal membranes ([@bib42]; [@bib31]; [@bib47]). We also identified EzrA, a cell division machinery component ([@bib58]), PurL, ClpB, ClpC, PknB, as well as the products of three uncharacterized genes: SAOUHSC_01854, SAOUHSC_02423, and SAOUHSC_01583. When analyzed for SpA trafficking via immunofluorescence microscopy, *S. aureus* mutants lacking EzrA, PBP2, PurL, ClpB, ClpC, PknB, SAOUHSC_01854, SAOUHSC_02423 (UDP-*N*-acetylglucosamine pyrophosphorylase), or SAOUHSC_01583 (conserved hypothetical phage protein) did not exhibit defects in septal precursor translocation ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). SecA and SecDF, members of the bacterial protein secretory pathway ([@bib36]; [@bib19]; [@bib43]), and LtaS, lipoteichoic acid synthase ([@bib22]), were selected for further study.

![Crosslinking of staphylococcal proteins to SpA~ED/S18L~ or SpA~ED/SP-SasF~.\
(**a**) Bacteria from *S. aureus* WY110 (pSpA~ED/S18L~) and *S. aureus* WY110 (pSpA~ED/\ SP-SasF~) cultures were crosslinked with 0.9% formaldehyde, membrane proteins detergent-solubilized and SpA~ED/S18L~ as well as SpA~ED/SP-SasF~ precursors purified by affinity chromatography on IgG-sepharose. Eluate was treated for 20 min at 95°C to reverse cross-linking or kept at 60°C (cross-linked control) and analyzed on Coomassie-stained SDS-PAGE. Bands were excised as indicated and individual proteins identified via ESI-MS analyses of tryptic peptides and data comparison with in silico trypsin-cleaved translation products derived from the genome sequence of *S. aureus*. Immunoblotting of 60 and 95°C samples to validate crosslinking of SpA~ED/S18L~ (**b**). The identity of the SpA-immunoreactive species migrating at 43 and 72 kDa in the left panel of [Figure 4b](#fig4){ref-type="fig"} is not known. (**c**) Bacteria from *S. aureus* WY110 (pSpA~ED~) and *S. aureus* WY110 (pSpA~ED/S18L~) cultures were treated with 0.9% formaldehyde (+crosslinker) or left untreated (- crosslinker), membrane proteins detergent-solubilized, and SpA~ED/S18L~ as well as SpA~ED~ precursors purified by affinity chromatography on IgG-sepharose. Eluate was treated for 20 min at 95°C to reverse crosslinking and samples analyzed by immunoblotting with antibodies specific for SpA and SecA (MW 95.96 kD). (**d**) Eluates of crosslinked SpA~ED/S18L~ and SpA~ED/SP-SasF~ precursors were examined by immunoblotting for the presence of SecA. See [Supplementary file 1](#supp1){ref-type="supplementary-material"} for a summary of proteins crosslinked to SpA~ED/S18L~.](elife-34092-fig4){#fig4}

SecA depletion in *S. aureus* {#s2-4}
-----------------------------

In *Escherichia coli*, *secA* is an essential gene ([@bib36]). SecA functions as an ATPase that moves many, but not all, precursor proteins across the SecYEG translocon ([@bib65]). To study the contribution of *secA* towards the septal secretion of SpA, we generated an inducible allele, P*~spac~-secA*, in *S. aureus* WY223 ([Figure 5a](#fig5){ref-type="fig"}). When induced with isopropyl β-D-1-thiogalactoside (IPTG), *S. aureus* WY223 (P*~spac~-secA*) forms colonies on agar and replicates in liquid media culture in a manner similar to wild-type *S. aureus* ([Figure 5bc](#fig5){ref-type="fig"}). However, in the absence of IPTG, *S. aureus* WY223 cannot form colonies ([Figure 5c](#fig5){ref-type="fig"}). Following dilution of bacteria from IPTG-containing media into broth without inducer, *S. aureus* WY223 replicates for 3 hr at a rate similar to wild-type ([Figure 5b](#fig5){ref-type="fig"}). Upon further dilution and incubation, *S. aureus* WY223 eventually exhibits growth retardation (6 hr time point). When analyzed by immunoblotting with SecA-specific antibody, SecA was already depleted in *S. aureus* WY223 (P*~spac~-secA*) cultures 3 hr following dilution into inducer free medium ([Figure 5d](#fig5){ref-type="fig"}). After 6 hr of incubation, SecA could no longer be detected ([Figure 5d](#fig5){ref-type="fig"}). These observations indicate that depletion of SecA does not cause immediate growth retardation in *S. aureus* WY223; SecA-depletion likely impairs replenishment of translocated proteins that are required for staphylococcal growth, which manifests after 6 hr of SecA depletion.

![Depletion of SecA in *S. aureus*.\
(**a**) Diagram of the *secA* gene locus in *S. aureus* RN4220 (wild-type parent, WT) and its P*~spac~*-s*ecA* variant. (**b**) Bacteria from overnight cultures of wild-type *S. aureus* and *S. aureus* P*~spac~*-s*ecA* grown in TSB with 1 mM IPTG were washed and suspended in fresh TSB with or without 1 mM IPTG. Subsequent growth was monitored as increased absorbance at 600 nm (A~600~). After three hours, cultures were diluted 1:100 into fresh TSB with or without 1 mM IPTG and incubated for additional growth measurements. (**c**) *S. aureus* P*~spac~*-s*ecA* was streaked on tryptic soy agar with or without 1 mM IPTG supplement and incubated for 16 hr at 37°C for growth. (**d**) Culture samples retrieved after 3 and 6 hr in (**b**) were analyzed by immunoblotting with antibodies against SecA (αSecA) and sortase A (αSrtA).](elife-34092-fig5){#fig5}

SecA depletion blocks SpA secretion {#s2-5}
-----------------------------------

After dilution into media with and without inducer, wild-type (*S. aureus* RN4220) and P*~spac~-secA* (*S. aureus* WY223) were subjected to pulse labeling with \[^35^S\]methionine and protein A precursor processing was analyzed by immunoprecipitation. In wild-type, SpA precursors are processed within 60 s; similar rates of processing were observed when the P*~spac~-secA* mutant was grown with IPTG inducer ([Figure 6a](#fig6){ref-type="fig"}). In the absence of IPTG, SpA precursor processing was slowed to about 5 min, indicating that SecA depletion inhibits precursor translocation ([Figure 6a](#fig6){ref-type="fig"}). When analyzed by fluorescence microcopy in trypsin-treated staphylococci incubated for 20 min without protease, wild-type *S. aureus* deposited protein A into the cross wall (*[Figure 6b](#fig6){ref-type="fig"}, yellow arrow*). Cross wall localization was diminished in P*~spac~-secA* mutant bacteria grown without IPTG inducer and restored to wild-type levels when bacteria were grown in the presence of inducer ([Figure 6c](#fig6){ref-type="fig"}). Six hours after dilution into broth without IPTG inducer, *S. aureus* WY223 (P*~spac~-secA*) cells were grossly enlarged and surrounded by a thin layer of peptidoglycan with aberrant cross-wall formation ([Figure 6d](#fig6){ref-type="fig"}, *blue arrow*); at this time point, SpA could not be detected in the bacterial envelope. As a control, growth of *S. aureus* WY223 in the presence of IPTG did not affect cell size and SpA deposition into the cell wall ([Figure 6d](#fig6){ref-type="fig"}).

![SecA depletion diminishes septal secretion of SpA in *S. aureus*.\
(**a**) SpA precursor processing of \[^35^S\]methionine pulse-labeled *S. aureus* RN4220 (WT) or *S. aureus* P~spac~-s*ecA* grown in the presence or absence of 1 mM IPTG. Bacteria were pulse-labeled for 60 s with radioactive methionine and then incubated with an excess of non-radioactive methionine. During the pulse (0') or 1 (1'), 5 (5') and 20 (20') min after the addition of excess unlabeled methionine, culture aliquots were withdrawn, precipitated with TCA, digested with lysostaphin, and subjected to SDS-PAGE and autoradiography of immunoprecipitated SpA. Wild-type *S. aureus* (WT) and its P*~spac~*-s*ecA* variant were grown for 3 (**b**) and 6 hr (**d**) in the presence or absence of 1 mM IPTG (see [Figure 5](#fig5){ref-type="fig"}). Samples in (**b**) were treated with trypsin to remove SpA from the bacterial surface. Bacteria were incubated for 20 min to allow for secretion and cell wall deposition of newly synthesized SpA. Samples were incubated with BODIPY-FL vancomycin (green) to stain the bacterial cell wall and with SpA-specific monoclonal antibody and Alexa Fluor 647-labeled secondary IgG (red) to reveal SpA. As a control for SpA-specific staining, the *S. aureus* ∆*spa* variant grown in the absence of IPTG was analyzed by fluorescence microscopy. (**c**) SpA-positive staphylococci in images derived from samples in (**b**) were analyzed for SpA deposition at the cross wall of diplococci (n = 200). Data from three independent experiments were used to derive the mean (± SEM) and were analyzed for significant differences with one-way ANOVA and *p* values recorded: RN4220-IPTG vs. RN4220 +IPTG, non-significant (ns); RN4220-IPTG vs. WY223-IPTG, p=0.0003; WY223-IPTG vs. WY223 +IPTG, p\<0.0001, RN4220 +IPTG vs. WY223 +IPTG, ns. (**e**) SecA depletion diminishes secretion of staphylococcal proteins. Protein samples from the extracellular supernatant (S) and bacterial pellet (P) of *S. aureus* RN4220 (WT) and *S. aureus* P*~spac~*-s*ecA* cultures grown for 3 hr in the presence or absence of 1 mM IPTG were analyzed by immunoblotting with antibodies against glycerol-ester hydrolase (αGeh) (precursor MW 76.39 kD, mature protein MW 72.26 kD), nuclease (αNuc) (precursor MW 25.12 kD, mature protein MW 18.78 kD) and sortase A (αSrtA). \*Identifies unknown proteins crossreactive with αGeh.](elife-34092-fig6){#fig6}

We wondered whether SecA depletion affects the secretion of other staphylococcal proteins. Glycerol-ester hydrolase (Geh) is synthesized as a precursor with YSIRK/GXXS signal peptide motif ([@bib29]). Following secretion at septal membranes into the cross-wall compartment, Geh is subsequently released into the extracellular medium ([@bib71]). When analyzed by immunoblotting of proteins in the extracellular medium, depletion of SecA in *S. aureus* WY223 (P*~spac~-secA*) caused a reduction in secreted Geh, as compared to wild-type staphylococci or *S. aureus* WY223 grown in the presence of IPTG ([Figure 6e](#fig6){ref-type="fig"}). Staphylococcal nuclease (Nuc), a secreted protein that contributes to the pathogenesis of human and animal infections, is synthesized as a precursor with a canonical signal peptide ([@bib40]; [@bib57]). The abundance of secreted Nuc was also diminished in SecA-depleted cultures of *S. aureus* WY223 ([Figure 6e](#fig6){ref-type="fig"}). As a control, production of sortase A in staphylococcal membranes was not affected by the depletion of SecA. Taken together, these data indicate that SecA is essential for *S. aureus* growth and for the secretion of precursors with canonical and YSIRK/GXXS signal peptides.

Localization of SecA and SpA precursors in staphylococci {#s2-6}
--------------------------------------------------------

To localize SecA within *S. aureus*, we generated a translational hybrid between *secA* and the structural gene for super-folder green fluorescent protein (*gfp*) ([@bib39]) under transcriptional control of the P*~tet~* promoter in *S. aureus* WY230 (P*~spac~-secA*, P*~tet~-secA:sfGFP*, [Figure 7a](#fig7){ref-type="fig"}). Expression of *secA:sfGFP* in the P*~spac~-secA* variant restored bacterial growth in the absence of IPTG inducer, indicating that *secA-gfp* is functional ([Figure 7b](#fig7){ref-type="fig"}). Growth restoration occurred in the presence and in the absence of anhydrotetracycline (ATc), suggesting that *secA:sfGFP* must be expressed even in the absence of the P*~tet~* inducer ([Figure 7b](#fig7){ref-type="fig"}). Immunoblotting of staphylococcal cell extracts 3 and 6 hr following dilution into media lacking IPTG revealed that *S. aureus* WY230 indeed produced small amounts SecA:sfGFP in the absence of ATc ([Figure 7c](#fig7){ref-type="fig"}). In the presence of ATc inducer, the abundance of SecA-GFP was increased ([Figure 7c](#fig7){ref-type="fig"}). As expected, wild-type SecA was depleted when *S. aureus* WY230 was cultured for 3 or 6 hr without the IPTG inducer ([Figure 7b](#fig7){ref-type="fig"}). However, under SecA depleting conditions, even small amounts of SecA-sfGFP in *S. aureus* WY230 (-ATc) restored precursor processing of pulse-labeled SpA ([Figure 7d](#fig7){ref-type="fig"}). SpA precursor processing was accelerated to levels faster than wild-type when *S. aureus* WY230 cultures were grown in the presence of ATc ([Figure 7d](#fig7){ref-type="fig"}). Fluorescence microscopy of *S. aureus* WY230 stained with the membrane dye FM4-64 (red) revealed SecA-sfGFP localization to plasma membranes ([Figure 7e](#fig7){ref-type="fig"}). In dividing cells, SecA-sfGFP was found on septal and on polar membranes ([Figure 7e](#fig7){ref-type="fig"}). ATc-induced overexpression of SecA-sfGFP caused accumulation of hybrid protein throughout plasma membranes ([Figure 7e](#fig7){ref-type="fig"}). Thus, in *S. aureus* WY230, SecA-sfGFP is associated with all membranes and is not restricted to septal membranes.

![SecA localization in staphylococci.\
(**a**) Diagram of the *secA* gene locus and of the pCL55-mediated *att* insertion site for *secA-sfGFP* in the staphylococcal genome. (**b**) Bacteria from overnight cultures of *S. aureus* RN4220 (WT), *S. aureus* P*~spac~*-s*ecA* (WY223) and *S. aureus* P*~spac~*-s*ecA*/P*~tet~-secA:sfGFP* (WY230) grown in TSB with 1 mM IPTG were washed and suspended in fresh TSB without IPTG and with or without 0.43 µM anhydro-tetracycline (ATc); growth was monitored as increased absorbance at 600 nm (A~600~). After three hours, cultures were diluted 1:100 into fresh TSB without IPTG and with or without 0.43 µM ATc and incubated for further growth measurements. (**c**) Culture samples retrieved after 3 and 6 hr from the experiment detailed in (**b**) were analyzed by immunoblotting with rabbit antibodies against SecA (αSecA) and sfGFP (αGFP). (**d**) \[^35^S\]methionine-labeled *S. aureus* cultures incubated for 3 hr as described in (**b**) were analyzed during the 60 s pulse with radioactive methionine (0) and 1, 5 and 20 min after the addition of excess unlabeled methionine via SDS-PAGE and autoradiography of immunoprecipitated SpA. (**e**) Fluorescence microscopy of bacteria from *S. aureus* cultures incubated for 3 and 6 hr as described in (**b**). Bacteria were stained with the membrane dye FM4-64 (red) and analyzed for SecA-sfGFP fluorescence (green). Scale bar, 1 µm.](elife-34092-fig7){#fig7}

The envelope of trypsin-treated, paraformaldehyde-fixed *S. aureus* WY223 (P*~spac~-secA*) was permeabilized with murein hydrolase and with detergent to detect intracellular precursors via microscopy with fluorescent antibody ([@bib23]; [@bib41]). In *S. aureus* WY223 producing wild-type levels of SecA (P*~spac~-secA* +IPTG), SpA precursors were localized to septal membranes ([Figure 8a](#fig8){ref-type="fig"}). In other images, SpA precursors appeared as two puncta or ring deposits at septal membranes, reminiscent of FtsZ and of the division rings that are known to accumulate at this site ([Figure 8ab](#fig8){ref-type="fig"}) ([@bib30]). In contrast, under SecA depleting conditions (-IPTG), SpA precursors in *S. aureus* WY223 were associated with polar membranes and were not localized to septal membranes ([Figure 8a](#fig8){ref-type="fig"}). These results suggest that in staphylococci with a functional secretion pathway, SpA precursor are localized to the vicinity of septal division rings. However, in cells lacking functional secretion machines, SpA precursors are located throughout the cytoplasm and cannot traffic to septal membranes.

![Intracellular trafficking of SpA in the presence and absence of SecA.\
(**a**) *S. aureus* P*~spac~*-s*ecA* cells were grown for 3 hr in the presence (+SecA) or absence of 1 mM IPTG (-SecA) and, alongside *S. aureus* ∆*spa* control cells, were trypsin treated to remove extracellular surface proteins and fixed with para-formaldehyde. Samples were then treated with lysostaphin (+Lysostaphin) or left untreated (-Lysostaphin), incubated with detergent and SpA-specific rabbit antibodies and Alexa Fluor 488-labeled goat-anti-rabbit-IgG (green) and with Nile red to reveal bacterial membranes. Bright-field microscopy (BF) images were acquired to reveal the contours of all bacterial cells. Scale bar, 1 µm. (**b**) Additional samples (\#1, \#2 and \#3) of *S. aureus* P*~spac~*-s*ecA* cells were grown in the presence of 1 mM IPTG (+SecA), trypsin treated, fixed with para-formaldehyde, lysostaphin treated, incubated with detergent and with SpA-specific antibody (green) and Nile red.](elife-34092-fig8){#fig8}

SecDF contributes to SpA secretion {#s2-7}
----------------------------------

The s*ecDF* gene is not essential for protein secretion and *S. aureus* growth, however *secDF* mutants exhibit diminished secretion of many precursors secreted via canonical and YSIRK-GXXS signal peptides ([@bib45]; [@bib44]). SecDF is a member of the resistance nodulation and cell division (RND) membrane protein family with 12-transmembrane spanning segments. SecDF functions as a membrane-integrated chaperone. Sustained by the proton motive force, SecDF catalyzes ATP-independent translocation and folding of proteins on the *trans*-side of the plasma membrane ([@bib67]). *S. aureus* expresses two additional RND proteins, here designated Rnd2 (SAOUHSC_02525) and Rnd3 (SAOUHSC_02866) ([@bib45]). The *rnd2* gene is located downstream of *femX*, whose product tethers glycine from glycyl-tRNA to the ε-amino group of lysine in lipid II peptidoglycan precursor \[C~55~-(PO~4~)~2~-MurNAc(L-Ala-D-iGln-L-Lys-Da-Ala-D-Ala)-GlcNac\] ([@bib48]). Rnd2 product interacts with FemB, PBP1 and PBP2 ([@bib45]). As SecDF, FemB and PBP2 were each found crosslinked to SpA~ED/S18L~ precursors ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), we asked whether *secDF*, *rnd2* and *rnd3* contribute to septal secretion of SpA. Compared to wild-type *S. aureus*, the Δ*secDF* mutant (*S. aureus* WY418) accumulated SpA~ED~ precursor in bacterial cells and secreted reduced amounts of mature SpA~ED~ into the extracellular medium ([Figure 9ab](#fig9){ref-type="fig"}). *S. aureus rnd2* (WY416) and *rnd3* (WY400) mutants exhibited wild-type levels of SpA~ED~ secretion ([Figure 9ab](#fig9){ref-type="fig"}). A variant (WY412) lacking all three genes, Δ*secDF* Δ*rnd23*, accumulated precursors at a level similar to the Δ*secDF* mutant ([Figure 9ab](#fig9){ref-type="fig"}). When analyzed for other secreted proteins, the Δ*secDF* mutant secreted diminished amounts of Geh and failed to secrete Coa, whose precursor is secreted via a canonical signal peptide ([@bib40]), while the Δ*rnd2* and Δ*rnd3* variants displayed wild-type phenotypes ([Figure 9ab](#fig9){ref-type="fig"}). Thus, SecDF, but not Rnd2 and Rnd3, contributes to protein secretion in *S. aureus*. Immunofluorescence microscopy experiments revealed that septal secretion of SpA was diminished in the ∆*secDF* and Δ*secDF* Δ*rnd23* mutants ([Figure 9c](#fig9){ref-type="fig"}). Unlike SecA-depleted cells, where SpA precursors failed to associate with septal membranes, ∆*secDF* and Δ*secDF* Δ*rnd23* mutants exhibited puncta of SpA precursors and rings of low fluorescent intensity at septal membranes ([Figure 9c](#fig9){ref-type="fig"}). The diminished abundance of SpA precursors at septal membranes was restored to wild-type levels by plasmid-borne expression of *secDF* in ∆*secDF* (pSecDF) and in Δ*secDF* Δ*rnd23* (pSecDF) staphylococci ([Figure 9c](#fig9){ref-type="fig"}). These data suggest that SecDF aids in the translocation of SpA across staphylococcal membranes but is not absolutely required for precursor targeting to septal membranes.

![SecDF contributes to SpA secretion at septal membranes.\
(**a**) *S. aureus* cultures were centrifuged to sediment the bacteria into the pellet (P) fraction and separate them from the extracellular medium (S, supernatant). Following lysostaphin digestion of bacteria, proteins in both fractions were precipitated with TCA and analyzed by immunoblotting with αSpA. (**b**) *S. aureus* cultures were fractionated as described in (**a**) and subjected to immunoblotting with antibodies specific for glycerol-ester hydrolase (αGeh), coagulase (αCoa) (precursor MW 71.72 kD, mature protein MW 68.96 kD) and sortase A (αSrtA). (**c**) Fluorescence microscopy of bacteria from cultures of *S. aureus* RN4220 (WT, wild-type), WY418 (∆*secDF*), WY416 (∆*rnd2*), WY400 (∆*rnd3*) and WY412 (∆*secDF* ∆*rnd23*) mutants with and without expression plasmid for wild-type *secDF* (pSecDF) as well as *S. aureus* SEJ1 (∆*spa*) *as* control. Bacteria were trypsin treated to remove extracellular surface proteins and fixed with para-formaldehyde. Samples were treated with lysostaphin, incubated with detergent and SpA-specific rabbit antibodies and Alexa Fluor 488-labeled goat-anti-rabbit-IgG (green) and with Nile red to reveal bacterial membranes. BF identifies the bright-field microscopy view of fluorescence microscopy images. Scale bar, 1 µm.](elife-34092-fig9){#fig9}

LtaS is required for septal localization of SpA {#s2-8}
-----------------------------------------------

LtaS-mediated synthesis of lipoteichoic acid, a polyglycerol-phosphate polymer decorated with esterified D-alanyl and GlcNAc residues, is essential for *S. aureus* growth and cell division ([@bib22]). Earlier work generated *S. aureus* P*~spac~-ltaS*, a strain with IPTG-inducible expression of lipoteichoic acid synthase ([Figure 10a](#fig10){ref-type="fig"}). In the absence of IPTG inducer, LtaS is depleted in *S. aureus* ANG499 (P*~spac~-ltaS*), providing an experimental system to study the effects of LTA synthesis on septal secretion of SpA ([@bib22]). Surface proteins were removed with trypsin and staphylococci were incubated for 20 min to localize deposition of newly synthesized SpA ([Figure 10bc](#fig10){ref-type="fig"}). LtaS depletion (-IPTG) resulted in SpA deposition into polar peptidoglycan, whereas under LtaS inducing conditions (+IPTG) SpA was localized in the cross-wall ([Figure 10bc](#fig10){ref-type="fig"}). We asked whether SpA precursors are mislocalized to polar membranes under conditions of LtaS depletion. Microscopic analysis of trypsin-treated, lysostaphin- and detergent-permeabilized staphylococci revealed SpA targeting to septal membranes in wild-type (*S. aureus* RN4220) and in IPTG-induced *S. aureus* ANG499 (P*~spac~-ltaS*)([Figure 10d](#fig10){ref-type="fig"}). In contrast, without IPTG inducer, *S. aureus* ANG499 mislocalized SpA precursors to polar membranes ([Figure 10d](#fig10){ref-type="fig"}). Protein secretion and cell wall anchoring of SpA were analyzed by immunoblotting in *S. aureus* cultures separated into culture supernatant (S) and bacterial sediment (P, pellet) samples. These experiments revealed that LtaS depletion in *S. aureus* ANG499 (P*~spac~-ltaS*, -IPTG) diminished the abundance of cell wall anchored SpA without affecting the secretion of Geh and Nuc ([Figure 10e](#fig10){ref-type="fig"}). Consistent with the immunoblotting results, LtaS depletion diminished the overall surface distribution of SpA ([Figure 10f](#fig10){ref-type="fig"}), in agreement with the hypothesis that cross-wall targeting via the YSIRK/GXXS signal peptide, but not polar secretion, is responsible for efficient surface distribution of proteins in staphylococci ([@bib8]; [@bib12]). Together these data indicate that LtaS depletion and a block in lipoteichoic acid synthesis abolished SpA precursor trafficking to septal membranes without affecting its secretion at polar membranes.

![Localization of SpA secretion in LtaS-depleted *S. aureus*.\
(**a**) Schematic to illustrate the *ltaS* locus in *S. aureus* RN4220 and ANG499. (**b**) Fluorescence microscopy with BODIPY-FL-vancomycin (green) and αSpA (red) stained samples 20 min after trypsin removal of surface proteins from the staphylococcal envelope to detect newly synthesized SpA. Scale bar, 2 µm. (**c**) SpA-positive staphylococci in images derived from samples in (**b**) were analyzed for SpA deposition at the cross wall of diplococci (n = 200). Data from three independent experiments were used to derive the mean (± SEM) and were analyzed for significant differences with one-way ANOVA for comparisons between *S. aureus* RN4220 (WT) and ANG499 grown with (+LtaS) and without IPTG (-LtaS). *p* values were recorded: RN4220-IPTG vs. ANG499-IPTG, p\<0.0001; ANG499-IPTG vs. ANG499 +IPTG, p\<0.0001. (**d**) Fluorescence microscopy to localize intracellular SpA in *S. aureus* strains RN4220 (WT) and ANG499 (P*~spac~-ltaS*) grown with and without IPTG induction for 3 hr. Bacteria were trypsin treated to remove extracellular surface proteins and fixed with para-formaldehyde. Samples were then treated with lysostaphin, incubated with detergent and SpA-specific rabbit antibodies and Alexa Fluor 488-labeled goat-anti-rabbit-IgG (green) and with Nile red to reveal bacterial membranes. BF identifies the bright-field microscopy view of fluorescence microscopy images. Scale bar, 2 µm. (**e**) The culture supernatant (S) and bacterial pellet (P) samples of *S. aureus* RN4220 and ANG499 grown for three hours in the presence or absence of IPTG were immunoblotted with antibodies specific for SpA (αSpA), glycerol-ester hydrolase (αGeh), coagulase (αCoa), nuclease (αNuc) and sortase A (αSrtA). (**f**) Fluorescence microscopy of staphylococci to measure surface display of protein A in bacteria stained with BODIPY-FL-vancomycin (green) and αSpA (red) without trypsin treatment. Scale bar, 2 µm.](elife-34092-fig10){#fig10}

Discussion {#s3}
==========

Cell wall-anchored surface proteins with YSIRK/GXXS motif signal peptides have been identified in streptococcal and staphylococcal species ([@bib59]; [@bib50]). Although sortase-anchored surface proteins are found in many different gram-positive bacteria, the signal peptides of surface proteins in the genus *Actinomyces, Bacillus*, *Clostridium*, and *Listeria* do not contain the YSIRK/GXXS motif. Common features of staphylococci and streptococci are their spherical or ovoid cell shapes and cell wall synthesis programs at septal membranes; in staphylococci this compartment is designated as the cross-wall ([@bib20]; [@bib64]; [@bib34]). Earlier work demonstrated that the YSIRK/GXXS motif of the SpA precursor is dispensable for sortase-catalyzed cell wall anchoring ([@bib4]). However, precursors with YSIRK/GXXS motif signal peptides are targeted for secretion at septal membranes and sortase-mediated deposition into the cross wall compartment ([@bib8]; [@bib12]). After completion of cross-wall synthesis, peptidoglycan splitting and cell separation, the anchored products of *spa* and of other genes with YSIRK/GXXS motif signal peptides are distributed over the bacterial surface ([@bib11]; [@bib13]). In contrast, surface proteins with canonical signal peptides are deposited by sortase into polar peptidoglycan but cannot be distributed over bacterial surfaces ([@bib8]; [@bib12]).

Although it is clear that YSIRK/GXXS signal peptides are necessary and sufficient for septal secretion of proteins, the mechanisms supporting such trafficking were heretofore not known. We show that the YSIRK/GXXS signal peptide of SpA is cleaved between Leu^12^ and Gly^13^, separating the YSIRK sequence from the GXXS motif and from the remainder of the signal peptide. Amino acid substitutions and deletions that affect precursor cleavage and secretion map to three of the four residues (underlined) that are strictly conserved in the YS[IR]{.ul}K/[G]{.ul}XX[S]{.ul} motif: Ile^9^, Arg^10^ and Ser^18^. Substitution of the fourth residue, Gly^15^, with Leu resulted in diminished abundance of precursor substrate and secreted product and in accumulation of a cleaved precursor species ([Figure 1b](#fig1){ref-type="fig"}). On the basis of these observations, we are compelled to speculate that YSIRK/GXXS motif cleavage may represent a mechanism for precursor translocation at septal membranes. For example, the YSIRK/GXXS motif may inhibit a key function of the adjacent hydrophobic core within signal peptides: promoting the membrane translocation of precursors. Such inhibitory mechanism could be relieved by a YSIRK/GXXS protease that localizes to the septal membrane. Other mechanisms of proteolytic control for YSIRK/GXXS mediated signal peptide function can also be thought of. Importantly, the discovery of two sequential proteolytic events, YSIRK/GXXS motif cleavage and the signal peptidase-mediated cut provide experimental opportunities for the testing of predictive models. SpA precursors were also cut between Gly^22^ and Thr^23^, a site that is located within the hydrophobic core of the signal peptide. Mass spectrometry analysis of the *S. aureus* COL secretome also identified signal peptide fragments that had been generated by cleavage in the hydrophobic core, including SpA signal peptides cleaved between Gly^22^ and Thr^23^ ([@bib46]). The significance of signal peptide cleavage in the hydrophobic core is not known, as amino acid substitutions preventing such proteolysis have not be studied for their effect on protein secretion or membrane integrity. We presume that cleavage at Gly^22^/Thr^23^ may not be related to septal secretion. Cleavage at the hydrophobic core may enable staphylococci to remove the products of processed signal peptides from the membrane. For example, products of degradative proteolysis have been observed during processing of SpA LPXTG motif sorting signal, which is cleaved between Thr (T) and Gly (G) and within the hydrophobic core ([@bib35]).

Precursors with amino acid substitutions or deletions in the YSIRK/GXXS motif are thought to accumulate in septal membranes, however these variants typically exhibit diminished secretion and cell wall anchoring in the cross wall ([@bib12]; [@bib71]). Our observations corroborate these findings and suggest that not all features of the YSIRK/GXXS motif are required for precursor targeting to septal membranes. We took advantage of the SpA~ED/S18L~ precursor and used affinity chromatography to purify crosslinked proteins. Several crosslinked proteins were already known to be located in septal membranes (PBP2, EzrA, LtaS), consistent with SpA~ED/S18L~ precursor accumulation in this compartment. Among the crosslinked proteins are two components of the secretion machinery, SecA and SecDF, as well as LtaS, which catalyzes the synthesis of lipoteichoic acid in septal membranes ([@bib65]; [@bib37]). SecA appears to bind directly to the signal peptide of SpA~ED/S18L~. The resulting complex may even engage SecYEG translocase as well as SecDF. However, due to the S18L substitution SpA~ED/S18L~ precursors cannot efficiently enter the septal secretion pathway. It seems unlikely that LtaS may directly interact with SpA~ED/S18L~. We think it is plausible that SpA~ED/S18L~ complexed with SecA and SecYEG at septal membranes can be crosslinked to other septal proteins.

The subcellular localization of the Sec apparatus has been examined in streptococci, enterococci and in *Bacillus subtilis*. A spiral pattern of Sec translocase has been reported for *B. subtilis* ([@bib7]). In *S. pyogenes*, contradictory results have been reported for immunogold-labelling and electron microscopy experiments: SecA was localized to a single microdomain and also found distributed throughout the plasma membrane ([@bib8]; [@bib49]). In *S. pneumoniae*, SecA localization changed during cell cycle progression. In early divisional cells, SecA was predominantly localized to septal membranes, whereas during later stages of division SecA was hemispherically distributed within the region between septa and at the future equators of dividing cells ([@bib66]). *Streptococcus agalactiae* SecA was localized to septal membranes, whereas SecA was detected as a single microdomain in *Streptococcus mutans* and *Enterococcus faecalis* ([@bib6]; [@bib24]; [@bib27]). We show here that *S. aureus* SecA is localized to the plasma membrane and is not spatially restricted to septal membranes or microdomains. This distribution is consistent with our proposed role of SecA, promoting precursor translocation at polar and septal membranes.

When studied for its contribution to septal secretion, SecDF chaperone allows large amounts of protein A to be deposited into the cross-wall peptidoglycan and promotes secretion of YSIRK/GXXS motif precursors (SpA and Geh). Nevertheless, *secDF* is not essential for septal targeting or secretion of SpA precursors. In contrast, cells depleted for SecA, accumulate SpA precursors that cannot traffic to septal membranes in the cytoplasm. Finally, LtaS-depleted staphylococci are unable to synthesize lipoteichoic acid and cannot direct precursors to the septal area. Instead, SpA is directed to polar membranes. We have incorporated these observations into a model whereby septal accumulation of LtaS and of lipoteichoic acids functions as a determinant for SecA-mediated targeting of SpA precursors. Following precursor cleavage at the YSIRK/GXXS motif, truncated SpA (SpA-2) is moved across the membrane, aided by the proton-motif force and by the chaperone activity of SecDF. Once translocated, SpA is cleaved by signal peptidase to generate SpA-4 and by sortase at the LPXTG motif of its C-terminal sorting signal ([@bib35]; [@bib61]). The resulting sortase-acyl intermediate is then incorporated into cross wall peptidoglycan for distribution on the bacterial surface ([@bib52]).

*Enterococcus faecalis* Eep, a membrane zinc-metalloprotease, cleaves signal peptides of lipoprotein precursors into short hydrophobic peptides that are subsequently dislodged from the membrane by an ABC transporter and function as pheromones to induce the transfer of conjugative plasmids by specific donors ([@bib2]; [@bib9]; [@bib69]). The corresponding zinc-metalloprotease in *S. aureus* is designated RseP (SAOUHSC_01239). However, RseP is not involved in septal secretion and cleavage of the YSIRK-GXXS signal peptides, as a deletion of the corresponding gene does not affect SpA septal secretion in the *S. aureus*Δ*SAOUHSC\_*01239 mutant ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

Materials and methods {#s4}
=====================

Bacterial strains and growth conditions {#s4-1}
---------------------------------------

*E. coli* strains were grown in Luria-Bertani broth (LB) or LB agar. *S. aureus* strains were grown in tryptic soy broth (TSB) or agar (TSA). Ampicillin (100 µg/ml) was used for plasmid selection in *E. coli*. Chloramphenicol was used for selection of pOS1 derivatives (10 µg/ml) and pCL55 derivatives (5 µg/ml) in *S. aureus* ([@bib28]). Erythromycin (Erm 10 µg/ml) was used for selection of *ermB* marked *bursa aurealis* transposon mutants in *S. aureus* WY110 (∆*spa* ∆*sbi*) and 10 µg/ml Erm plus 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was used for pMutin--HA-5'secA selection in *S. aureus*. Expression from the P*~spac~* promoter was induced with 1 mM IPTG. Anydrotetracycline (ATc, 200 ng/ml) was used to induce expression from the tetracycline-inducible promoter in pCL55-P*~tet~* constructs.

Plasmids and strains {#s4-2}
--------------------

To avoid mutations in the *spa* gene, all cloning procedures were performed at 30°C. All pOS1-derivative and pCL55-derivative plasmids were constructed in *E. coli* DC10B ([@bib33]) and transformed to *S. aureus* strains by electroporation ([@bib54]). All plasmids and strain constructs were validated by DNA sequencing ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Primers used in this study are listed in [Supplementary file 3](#supp3){ref-type="supplementary-material"}. To avoid cross reaction in SpA immunoblot and purification, *S. aureus* WY110 (∆*spa* ∆*sbi)* was generated by transducing *the sbi::ermB* allele from the Phoenix library ([@bib3]) into *S. aureus* SEJ1, that is *S. aureus* RN4220 carrying ∆*spa.* Phage transduction was performed as described previously ([@bib54]). To construct pSpA~ED~, primers 10 and 69 were used to amplify the *spa* promoter and *spa~ED~* coding sequence encoding IgBDs E and D (−40 bp upstream of the transcription start site of *spa* to 459 bp of *spa* coding sequence) from chromosomal DNA of *S. aureus* RN4220. The PCR product was digested with EcoRI and BamHI, and ligated with plasmid pOS1 ([@bib53]). To generate mutations and deletions within the SpA signal peptide sequence, quick-change mutagenesis was performed as follows: primers pairs ([Supplementary file 3](#supp3){ref-type="supplementary-material"}) that contain desired mutation or deletion were used to PCR amplify pSpA~ED~. The PCR products were digested with DpnI and transformed to *E. coli* DC10B. Plasmid variants confirmed by DNA sequencing were transformed into *S. aureus* WY110. To construct pCL55-SpA and its derivatives, primer pairs 175 and 177 were used to PCR amplify the *spa* promoter and full-length *spa* coding sequence. PCR products were digested with BamHI and KpnI and ligated into pCL55 cut with the same enzymes ([@bib28]). The resulting plasmid, pCL55-SpA, was used as template for PCR mutagenesis of its signal peptide mutant derivatives via quick-change mutagenesis as described above. To construct pCL55-SpA~SP-SasF~, primer pairs 175 and 21 were used to amplify the promoter sequence of *spa*. Primers 22 and 23 were used to amplify coding sequence for the signal peptide sequence of *sasF.* Last, primers 24 and 177 were used amplify *spa* coding sequence for the E and D IgBDs. All three DNA fragments were ligated via SOE (splicing by overlap extension) PCR, digested with BamHI and KpnI, and then ligated into pCL55 cut with the same restriction enzymes. pCL55-derivaties were transformed into *S. aureus* WY110 and integrated into the chromosome at the *geh* locus ([@bib28]). The integration was confirmed by PCR. To construct the *secA* depletion strain *S. aureus* WY223 (P*~spac~-secA*), primers 189 and 190 were used to amplify the ribosome binding site and the first 656 bp of the *secA* gene. The PCR product was digested with HindIII and KpnI and ligated with pMutin--HA (Bacillus Genetic Stock Center, Columbus, OH). The resulting plasmid pMutin--HA-5'secA was transformed into RN4220 and integrated at the *secA* locus in the chromosome. Clones were selected on TSA supplemented with 10 µg/ml erythromycin and 1 mM IPTG. To construct pCL55-P*~tet~-secA:sfGFP*, primers 180 and 181 were used to amplify *secA* full-length coding sequence together with its ribosome binding site. Primers 182 and 183 were used to amplify *sfGFP* gene from pCX-sfGFP ([@bib71]). The two DNA fragments were joined together by SOE. The resulting *secA:sfGFP* hybrid, which contains the 'Gly-Gly-Ala-Ala-Gly-Ala' between SecA and sfGFP, was digested with AvrII-BglII and ligated with pCL55-P*~tet~* ([@bib22]). pCL55-P*~tet~-secA:sfGFP* was transformed to into *S. aureus* WY223 (P*~spac~-secA*) and integrated into the chromosome at the *geh* locus, thereby generating *S. aureus* WY230 (*P~spac~-secA,* P*~tet~-secA:sfGFP*). Plasmid pKOR1 based allelic replacement ([@bib5]) was used to generate the ∆*secDF* (*S. aureus* WY418) and ∆*rnd2* (*S. aureus* WY416) knock-out mutants. *S. aureus* WY412, a mutant with ∆*secDF* ∆*rnd23* mutations, was generated by transducing *the rnd3::ermB* allele from the Phoenix library into *S. aureus* carrying ∆*secDF* and ∆*rnd2* mutations. To construct the complementation plasmid pSecDF, the *secDF* ORF and 274 bp upstream sequence were PCR amplified with primers 315 and 316, digested with EcoRI and BamHI, and ligated into pOS1 cut with the same enzymes. The resulting plasmid, pSecDF, was transformed into *S. aureus* strains WY418 (∆*secDF*) and WY412 (∆*secDF* ∆*rnd23*).

Cell fractionation and immunoblotting {#s4-3}
-------------------------------------

Bacterial overnight cultures were diluted 1: 100 into fresh TSB and grown to OD~600~ 0.8. One ml culture was centrifuged at 18,000 × *g* for 5 min in an Eppendorf tube. The culture supernatant (S) was transferred to another tube and proteins were precipitated with 10% trichloroacetic acid (TCA) on ice for 30 min. The bacterial sediment (P, pellet) was suspended in 1 ml Tris-buffer \[50 mM Tris-HCl (pH 7.5), 150 mM NaCl\] and incubated with 20 µg/ml lysostaphin at 37°C for 30 min. After cell lysis, proteins from the cell pellet were precipitated with 10% TCA. To localize proteins in different cellular compartments, cell fractionation was performed as follows: 1 ml culture (OD~600~ = 0.8) was centrifuged at 18,000 × *g* for 5 min in an Eppendorf tube. The supernatant was transferred to another tube and proteins were precipitated with 10% TCA (S, supernatant). The pellet was suspended in 1 ml TSM \[50 mM Tris-HCl (pH 7.5), 0.5 M sucrose, 10 mM MgCl~2~\] and incubated with 20 µg/ml lysostaphin for 10 min at 37°C. After centrifugation at 18,000 × *g* for 5 min, the supernatant (cell wall fraction) was transferred to another tube. The protoplast pellet was suspended in 1 ml Tris-buffer \[50 mM Tris-HCl (pH 7.5), 10 mM MgCl~2~\] and subjected to three freeze-thaw cycles in dry ice/ethanol and warm water baths. Membranes in cell lysates were sedimented by ultracentrifugation 150,000 × *g* for 40 min. Supernatant was transferred to another tube (cytosolic fraction), whereas the pellet (membrane fraction) was suspended in 1 ml Tris-buffer and precipitated with 10% TCA. After TCA precipitation on ice for 30 min, proteins were sedimented at 18,000 × *g* for 10 min, washed with ice-cold acetone, air-dried and solubilized in 100 μl 1 × SDS sample buffer \[62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.01% bromophenol blue\]. For immunoblotting, protein samples were separated on 10, 12 or 15% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were blocked with 5% milk for 45 min. As needed, 50 μl human IgG (Sigma) was added to 10 ml block-solution to block SpA cross-reaction. Primary antibodies were affinity-purified rabbit polyclonal antibodies against SpA~KKAA~ (1:10,000 dilution), rabbit serum of anti-SrtA (1:20,000 dilution), rabbit serum of anti-SecA (1:10,000 dilution), rabbit serum of anti-Geh (1:10,000 dilution), polyclonal antibodies of anti-Coa (1:5000 dilution), rabbit serum of anti-Nuc (1:5000 dilution), and anti-GFP rabbit serum (1:10,000 dilution) (Invitrogen). Membranes were incubated with primary antibodies for 1 hr, washed three times for 5 min with TBST \[50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Tween 20\], incubated with secondary anti-rabbit IgG linked to horseradish peroxidase (HRP) for 1 hr, washed, and developed using enhanced chemiluminescence substrates. The intensity of immunoblot signals was analyzed and measured with Image J software ([@bib56]). Statistical analysis was performed using GraphPad Prism software. One-way ANOVA (Dunnett\'s multiple comparisons test) was used to compare the mean for each variant with the mean for SpA~ED~ wild-type ([Figures 1c](#fig1){ref-type="fig"} and [2b](#fig2){ref-type="fig"}).

Pulse-labeling {#s4-4}
--------------

Staphylococcal cultures were grown to mid-log phase (OD~600~ 0.8) in TSB and bacteria sedimented by centrifugation at 18,000 × *g* for 5 min. Bacterial pellets were washed twice and suspended in 1 ml minimal medium 4. \[^35^S\]methionine/cysteine (100 µl = 100 µCi Perkin Elmer) was added to bacterial suspensions, vortexed and incubated for 60 s at 37°C. 250 µl was removed and immediately mixed with 250 µl ice-cold 10% TCA to quench all metabolic activity (time 0'). Chase solution (50 µl of 2 mg/ml methionine, 2 mg/ml cysteine and 10 mg/ml casamino acids) was added to the remainder of bacterial suspension and incubated for 1, 5 and 20 min. At each time point, 250 µl bacterial suspension was removed and mixed with 250 µl ice-cold 10% TCA. TCA precipitated cells were washed with acetone, dried and suspended in 1 ml 0.5 M Tris-HCl (pH 7.0) containing 20 µg/ml lysostaphin. After lysostaphin treatment at 37°C for 1 hr, cell lysate was precipitated with 7% TCA, washed with acetone, dried, suspended in 50 µl 4% SDS, 0.5 M Tris-HCl (pH 7.5) and allowed to incubate for 30 min prior to boiling. Subsequently, samples were incubated for 1 hr with rabbit polyclonal anti-SpA~KKAA~ antibody ([@bib25]) that was 1:1000 diluted in 1 ml RIPA buffer (0.1% SDS, 0.5% deoxycholic acid, 1% Triton X-100, 50 mM Tris-HCl pH 8.0, 150 mM NaCl). Protein A sepharose (50 µl of 50% slurry, Sigma) was added to each sample and incubated for 1 hr followed by five washes with 1 ml RIPA buffer. Proteins bound to the beads were solubilized by boiling in 15 µl 2 × SDS sample buffer for 10 min and separated on 10% (SpA) or 15% SDS-PAGE (SpA~ED~). Gels were dried on Whatman 3 M paper and autoradiographed on X-ray film for 48 hr or longer.

Purification of SpA~ED/S18L~, Edman degradation and MALDI-TOF mass spectrometry {#s4-5}
-------------------------------------------------------------------------------

Overnight bacterial cultures of *S. aureus* WY110 (pSpA~ED~ or its derivatives) were diluted 1:100 into 4 liters of TSB and grown to OD~600~ 2. Staphylococci were sedimented by centrifugation at 8,000 × *g* for 10 min. Bacteria were suspended in 30 ml of Tris-buffer, 0.5 (vol/vol) 0.1 mm sterilized glass beads were added and peptidoglycan was broken with 15 × 1 min pulses in a bead-beating instrument (MP Biomedicals). Samples were centrifuged at 7,000 × *g* for 10 min to sediment glass beads. The supernatant was transferred to another tube and centrifuged at 33,000 × *g* for 1 hr at 4°C. The membrane sediment was suspended in 30 ml RIPA buffer and incubated for 1 hr with rotation. RIPA extract was centrifuged at 33,000 × *g* for 1 hr at 4°C. The supernatant was removed and subjected to affinity chromatography. Two ml 50% suspension of IgG sepharose (GE Healthcare) was loaded onto each column. The column bed was washed once with 7 ml 0.1 M glycine (pH 3.0), twice with 14 ml 50 mM Tris-HCl (pH 7. 5) and once with 10 ml RIPA buffer. RIPA membrane extracts were loaded onto the column followed by two washes with 14 ml RIPA buffer and once with 10 ml 50 mM Tris-HCl (pH 7. 5). Proteins were eluted by adding four times 1 ml 0.1 M glycine (pH 3.0) to the column and immediately neutralizing the eluate with 25 µl of 1.5 M Tris (pH 8.8). For Edman degradation, the purified SpA~ED~ precursors were 10-fold concentrated via Amicon Ultra-0.5 ml Centrifugal Filters (10 kD cut off). Proteins were separated on 15% SDS-PAGE, electro-transferred to PVDF and stained with Coomassie-Brilliant Blue. Bands of interest were excised and subjected to Edman degradation (Alphalyse, Inc, CA, USA). For MALDI-TOF mass spectrometry analysis, 1 µl of SpA~ED~ sample was mixed with 1 µl of 10 mg/ml sinapic acid, dried on the Bruker MTP 384 plate, and examined in a Bruker Autoflex Speed MALDI-TOF mass spectrometer in the linear positive-ion mode using peptide standards for calibration.

Crosslinking of SpA~ED~ precursor {#s4-6}
---------------------------------

Overnight cultures of *S. aureus* WY110 (∆*spa* ∆*sbi,* pSpA~ED/S18L~) and *S. aureus* WY110 (∆*spa* ∆*sbi,* pSpA~ED/SP-SasF~) were each diluted 1: 100 into 4 L TSB and grown to OD~600~ 2. Formaldehyde (0.9%, methanol free) was added to the bacterial culture and incubated for 20 min with shaking. Cross-linking was quenched by adding 400 ml ice-cold 0.125 M glycine and rotating the sample for 10 min. Staphylococci were sedimented by centrifugation at 8,000 × *g* for 10 min. Bacteria were suspended in 30 ml of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and washed twice in the same buffer. Sterilized 0.1 mm glass beads 0.5 (vol/vol) were added and peptidoglycan broken with 15 × 1 min pulses in a bead-beating instrument (MP Biomedicals). Samples were centrifuged at 7000 × *g* for 10 min to sediment glass beads. The supernatant was transferred to another tube and centrifuged at 33,000 × *g* for 1 hr at 4°C. The membrane sediment was suspended in 30 ml 50 mM Tris-HCl (pH 7. 5), 2% n-dodecyl β-D-maltoside (DDM) and incubated at 4°C overnight. Samples were subjected to ultracentrifugation at 150,000 × *g* for 40 min. The supernatant was subjected to affinity chromatography on IgG sepharose affinity purification as described above. Eluate was concentrated via Amicon Ultra-0.5 ml 10 kD Centrifugal Filters and mixed with equal volume of 2 × SDS sample buffer. To reverse the cross-linking, samples were either boiled at 95°C for 20 min or, as a control, incubated at 60°C (no reversal of cross-linking). Proteins in all samples were separated on 12% SDS-PAGE and bands of interest excised as indicated in [Figure 4](#fig4){ref-type="fig"} and subjected to protein identification and semi-quantitative analysis at the Harvard University Taplin Mass Spectrometry Facility ([Supplementary file 1](#supp1){ref-type="supplementary-material"}).

SecA depletion and SecA-sfGFP induction {#s4-7}
---------------------------------------

Overnight cultures of *S. aureus* RN4220 (WT), *S. aureus* WY223 (P*~spac~-secA*) and *S. aureus* WY230 (P*~spac~-secA,* P*~tet~-secA:sfGFP*) were grown in TSB and 1 mM IPTG. Overnight cultures were washed twice with an equal volume of TSB and diluted 1:100 into fresh TSB with or without 1 mM IPTG and with or without 200 ng/ml ATc. After 3 hr growth at 37°C, cultures were diluted into fresh TSB with or without IPTG or ATc and subjected to further growth at 37°C. Growth was monitored by sampling cultures at timed intervals and measuring optical density. One ml bacterial culture was removed after 3 hr (prior to the second 1:100 dilution) and after 6 hr (3 hr after the second 1:100 dilution). Samples were processed for protein secretion and immunoblotting assays or analyzed by fluorescence microscopy. A similar procedure was performed for LtaS depletion using *S. aureus* ANG499 (P*spac-ltaS*). Samples from the LtaS depletion experiments were analyzed after 3 hr growth with or without 1 mM IPTG.

Fluorescence microscopy {#s4-8}
-----------------------

To observe SpA targeting to the cross-wall, 2 ml mid-log phase *S. aureus* culture (OD~600~ 0.8) were centrifuged at 18,000 × *g* for 5 min, supernatant removed, bacteria washed once in 2 ml PBS and suspended in 1 ml PBS containing 0.5 mg/ml trypsin (Sigma). After incubation at 37°C for 1 hr, staphylococci were washed twice with PBS, suspended in fresh TSB containing 2.5 mg/ml soybean trypsin inhibitor (Sigma) and incubated at 37°C for 20 min with rotation. 250 µl of the cell suspension was removed and immediately mixed with fixation solution (2.5% paraformaldehyde and 0.006% glutaraldehyde in PBS). The cells were fixed for 20 min at room temperature, washed three times with PBS and applied to poly-L-lysine coated 8-well glass slides (MP Biomedicals) for 5 min. Excess and non-adherent cells were washed away with PBS. Immobilized cells were blocked with 3% BSA in PBS for 45 min and incubated with SpA-specific mouse hybridoma monoclonal antibody 5A10 ([@bib25]) (diluted 1:4000 in 3% BSA) for 1 hr. Cells were washed eight times with PBS and further incubated in the dark with Alexa Fluor 647 conjugated anti-mouse IgG (1:500 in 3% BSA) (Invitrogen, Carlsbad, CA) for 1 hr. Cells were washed 10 times with PBS and incubated with 1 µg/ml BODIPY-FL vancomycin (ThermoFisher) for 10 min in the dark followed by washing five times with PBS. A drop of SlowFade Gold reagent (Molecular Probes) was applied to samples before sealing coverslips with nail polish. Fluorescent images were visualized and captured on a Leica SP5 Tandem Scanner Spectral 2-Photon Confocal microscope with 100 × oil objective. Identical settings and exposure times were applied to all samples.

To image SpA display on the staphylococcal surface, 1 ml of mid-log phase *S. aureus* cultures were centrifuged at 18,000 × *g* for 5 min and supernatant removed. Bacteria were washed once in 2 ml PBS and suspended in 1 ml PBS and mixed with fixation solution. Cells were fixed for 20 min at room temperature, washed three times with PBS and applied to poly-L-lysine coated 8-well glass slides (MP Biomedicals) for 5 min, stained with vancomycin and αSpA antibodies and analyzed by fluorescence microscopy.

To localize intracellular SpA, 2 ml of mid-log phase staphylococcal cultures were centrifuged at 18,000 × *g* for 5 min and supernatant removed. Bacteria were washed once in 2 ml PBS and suspended in 1 ml PBS, 0.5 mg/ml trypsin (Sigma). After incubation at 37°C for 1 hr, staphylococcal cells were washed twice with PBS and fixed with fixation solution. The cells were fixed for 15 min at room temperature and 30 min on ice, washed three times with PBS and suspended in 1 ml GTE buffer \[50 mM glucose, 20 mM Tris-HCl (pH 7.5), 10 mM EDTA\]. Lysostaphin (10 µg/ml) was added and 50 µl cell suspensions were immediately applied to poly-L-lysine coated 8-well glass slides and incubated for 1 min. Non-adherent cells were removed and PBS, 0.2% Triton X-100 was applied to samples for 10 s. Excessive liquid was aspirated and slides were air-dried. Dried slides were immediately dipped in methanol at −20°C for 5 min, and in acetone at −20°C for 30 s and then allowed to dry completely. Afterwards, the cells on the slides were re-hydrated with PBS for 5 min, blocked with 3% BSA, stained with the membrane dye Nile red (Sigma) and rabbit antibodies specific for SpA followed by Alexa-Fluor-488 conjugated goat-anti-rabbit-IgG and analyzed by fluorescence microscopy as described above.

To visualize the sub-cellular localization of SecA-sfGFP, samples from 3 and 6 hr growth cultures were removed as described above. Bacteria were sedimented by centrifugation and washed twice in PBS. Cells were stained with 1 µg/µl FM4-64FX (Molecular Probes) for 10 min in the dark and were then fixed with fixation solution for 20 min. After washing twice with PBS, cells were applied to poly-L-lysine coated coverslips, and incubated for 5 min. After removing excess bacterial cells, SlowFade Gold reagent was added to the samples and the coverslips were sealed onto glass slides. Samples were visualized under Leica SP8 3D, 3-color Stimulated Emission Depletion (STED) laser scanning confocal microscope with 100×/1.45 oil objective. Images were captured with identical settings. Deconvolution images with identical parameters were generated by using a HyVolution module installed on the microscope.

All the images were analyzed in Image J software ([@bib56]). To quantify the frequency of SpA cross-wall localization at 20 min regeneration after trypsin digestion, numbers of diplococci and numbers of cross-wall localized SpA were counted manually using the cell counter tool in Image J. Diplococci were defined as two daughter cells that had divided and formed a cross-wall but had not yet separated. Cross-wall localized SpA signals were defined as lines at the cross-wall of diplococci. Diplococci were counted in vancomycin stained images and cross-wall localized SpA was counted in merged images. The frequency was determined by dividing cross-wall localized SpA by the number of diplococci. An example of the counting method is displayed in the Source file to [Figure 2e](#fig2){ref-type="fig"}. At least two random images were acquired per sample for each experiment. Three or more independent experiments were performed and data from more than 200 diplococci were analyzed for statistically significant differences using one-way ANOVA with Dunnett\'s multiple comparison test comparing staphylococci expressing wild-type and *spa* variants ([Figure 2e](#fig2){ref-type="fig"}). In [Figure 6c](#fig6){ref-type="fig"} and [Figure 10c](#fig10){ref-type="fig"} the Tukey\'s multiple comparison test was used to analyze differences between multiple groups.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Septal Secretion of Protein A in *Staphylococcus aureus* Requires SecA and Lipoteichoic Acid Synthesis\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Richard Novick (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This is very thorough and detailed analysis of the role of the YSIRK/GXXS motif in septal secretion in staphylococci and, by implication, in other /gram-positive bacteria. It will add substantively to our understanding of protein secretion in the organisms.

Two reviewers carefully read and commented on the manuscript. Revisions should be straightforward. Reviewer 3 has three major concerns, which I anticipate you will be able to address. The first of these concerns is a sort of organizational issue. Dr. Novick has posed two questions, which you might want to address in your revised manuscript. Normally, we would consolidate the reviews into one document indicating essential revisions, but everything seems to be very straightforward here and we are just including the two reviews in their entirety.

*Reviewer \#2:*

This is very thorough and detailed analysis of the role of the YSIRK/GXXS motif in septal secretion in staphylococci and, by implication, in other /gram-positive bacteria. It will add substantively to our understanding of protein secretion in the organisms.

I have only a few suggestions for improvement of the paper, plus 2 major questions, of which the answers would add nicely to the presentation (but are not really required): why is SecA required for growth, and which proteases catalyze the cleavages within the signal peptide?

Abstract and the last paragraph of the Introduction -- confusing and difficult to understand; does not really convey a clear message -- should be rewritten.

Introduction, first paragraph -- are all proteins with the YSIRK/GXXS motif trafficked to the septal membrane?

Introduction, second paragraph -- \"relieved\"? Replace with \"cleaved\" or \"disrupted\".

Subsection "SpA signal peptide variants defective for septal secretion", first paragraph -- is the nature of this faster-moving precursor known?

Subsection "SpA signal peptide variants defective for septal secretion", last paragraph -- delete \"encoding the\" and \"variants\".

Subsection "SpA signal peptide variants defective for septal secretion", last paragraph -- explain \"SpASP-SasF\".

Subsection "Processing of SpA signal peptide variants" -- the hydrophobic portion of staphylococcal signal peptides have been observed to serve as sex pheromones promoting conjugation with enterococci. Could this be the role of the peptide produced by this cleavage? What protease is responsible for the YSIRK/GXXS cleavage?

Subsection "SecA depletion in *S. aureus*" -- Figure 5B does not appear to show the patterns described in the text -- e.g. there is no growth arrest of secA-depleted cells, and it is noted later that there is residual SecA is present. These points should be made consistent.

Subsection "SecA depletion blocks SpA secretion", last paragraph -- any idea why secA mutants are defective for growth? Could it be required for cell division as perhaps suggested by the observations described in the last paragraph of the subsection "Localization of SecA and SpA precursors in staphylococci"?.

*Reviewer \#3:*

The gap in knowledge that this study aims to address is: How are YSIRK/GXXS-containing proteins directed to the septal membrane for localized secretion? The authors identify YSIRK/GXXS signal peptide interacting partners and create a beautiful series of conditional mutant strains in order to query the role of a subset of those interacting partners in SpA septal targeting. Overall, the experimental design and execution was very nice and I especially appreciated the abundance of controls at every stage.

The major findings in this study are 1) SpA signal peptide variant interacts with SecA and LtaS, and 2) SecA or LtaS depletion results in SpA not at the septum but diffuse around the cell in the case of SecA -- and polar in the case of LtaS (Figure 8 and 10).

Secondary findings in this study are 1) the identification of SpA signal sequence residues that are important for precursor processing and SpA secretion, 2) cleavage sites within the SpA signal sequence, and 3) the unsurprising report that depletion of SecA or deletion of SecDF result in reduced secretion of several secreted proteins.

Major comments:

While the cumulative data in the paper support the title that SpA septal secretion requires SecA, there are numerous instances earlier in the paper, before the key data to support this are shown (in Figure 8) where statements to this effect are made. For example, the first section title indicates SpA signal peptide variants are defective for septal secretion when the data presented in this section only support a general secretion phenotype. There are other premature examples of this and I found it confusing and later misleading. I suggest this be modified throughout the manuscript.

The crosslinking and pulldown experiments used a mutant SpA precursor that appears to accumulate at higher levels than WT in general, and accumulates at the septum. While (I think) I understand the rationale for using this construct for pulldowns (they are enriched at the septum so interactions are more likely), I wonder if it could lead to \'forced\' interactions and/or miss other interactions with wild type SpAED. Did the authors also try using SpAED? What happened? Can these interactions be validated in the absence of crosslinks (either for the mutant or WT signal sequence) by bacterial two hybrid or another method, to confirm if they are direct or indirect interactions? And why were SecA, SecDF, and LtaS singled out for further analysis?

I am puzzled by the data presented in Figure 7 and 8: on one hand, SecA is everywhere (Figure 7), but upon depletion (albeit the conditions used here are unclear) SpA becomes diffuse (presumably in the membrane?) (Figure 8). Since the cells don\'t look sick (as in Figure 6D), this must be a mild SecA depletion. So the residual SecA is presumably everywhere in the membrane, but is not interacting with SpA at the septum? Why not? What provides the specificity for this localized interaction? Why does YSIRK/GXXS interact with only a subset of SecA molecules at the septum when SecA is everywhere? This key question remains unclear to me.

10.7554/eLife.34092.020

Author response

> Reviewer \#2:
>
> \[...\] I have only a few suggestions for improvement of the paper, plus 2 major questions, of which the answers would add nicely to the presentation (but are not really required): why is SecA required for growth?

In *E. coli, secA* is required for bacterial growth because the sum of all secreted proteins contributes to bacterial replication. About one third of all proteins are secreted across the plasma membrane or inserted into the plasma membrane. We presume the same applies to *S. aureus*. For example, when *secA* is depleted for 3 hours, staphylococcal growth is not yet impaired albeit that SecA is undetectable by immunoblotting (Figure 5D and Figure 7C). After 6 hours of incubation without production of new SecA, staphylococci cease growth presumably because insufficient amounts of secreted proteins are available for the uptake of nutrients, energy production, membrane hemostasis and cell division. The text has been modified to make this clear (subsection "SecA depletion in *S. aureus*").

> And which proteases catalyze the cleavages within the signal peptide?

We don't know the answer to this question.

> Abstract and the last paragraph of the Introduction -- confusing and difficult to understand; does not really convey a clear message -- should be rewritten.

We have rewritten this section as requested (Abstract and Introduction, last paragraph).

> Introduction, first paragraph -- are all proteins with the YSIRK/GXXS motif trafficked to the septal membrane?

Yes. Our previous work demonstrated that all proteins with YSIRK/GXXS signal peptide travel to the staphylococcal septum.

> Introduction, second paragraph -- \"relieved\"? Replace with \"cleaved\" or \"disrupted\".

We replaced "relieved" with "resolved".

> Subsection "SpA signal peptide variants defective for septal secretion", first paragraph -- is the nature of this faster-moving precursor known?

Yes. We have purified the precursors and identified their amino acid sequence, which correspond to SpA~ED/R10A~-2 and SpA~ED/S18L~-2 in Figure 3.

> Subsection "SpA signal peptide variants defective for septal secretion", last paragraph -- delete \"encoding the\" and \"variants\".

The text has been changed. We did not use the reviewer's recommendation, as amino acid substitutions do not represent mutations.

> Subsection "SpA signal peptide variants defective for septal secretion", last paragraph -- explain \"SpASP-SasF\".

SpA~SP~-SasF is now explained in the text.

> Subsection "Processing of SpA signal peptide variants" -- the hydrophobic portion of staphylococcal signal peptides have been observed to serve as sex pheromones promoting conjugation with enterococci. Could this be the role of the peptide produced by this cleavage? What protease is responsible for the YSIRK/GXXS cleavage?

The reviewer refers to beautiful work in *Enterococcus faecalis*, where Eep, a membrane zinc-metalloprotease, cleaves signal peptides of lipoprotein precursors into short hydrophobic peptides that are subsequently dislodged from the membrane by an ABC transporter and function as pheromones to induce the transfer of conjugative plasmids by specific donors. The corresponding zinc-metalloprotease in *S. aureus* is designated RseP. We already know that RseP is not involved in the cleavage of the YSIRK-GXXS signal peptides (Figure 4---figure supplement 1). We believe this makes sense, as the signal peptides of lipoproteins do not share sequence similarity with the YSIRK-GXXS signal peptide. Earlier work demonstrated that *S. aureus* produces pheromone peptides for mating with *E. faecalis*, however the corresponding peptides are not derived from precursors with YSIRK-GXXS signal peptides. Thus, RseP/Eep is not involved in cleaving YSIRK-GXXS signal peptides and the cleavage products of YSIRK-GXXS signal peptides are not thought to function as pheromone signals for mating. We have introduced some of these arguments in the Discussion (last paragraph) to explain the seemingly parallel events between the two signal peptide cleavage systems. See also data in the new Figure 4**---**figure supplement 1.

> Subsection "SecA depletion in S. aureus" -- Figure 5B does not appear to show the patterns described in the text -- e.g. there is no growth arrest of secA-depleted cells, and it is noted later that there is residual SecA is present. These points should be made consistent.

We have expanded the text to say that growth arrest in SecA-depleted staphylococci occurs after 6 hours of incubation, not after 3 hours, and that SecA product is depleted as early as 3 hours.

> Subsection "SecA depletion blocks SpA secretion", last paragraph -- any idea why secA mutants are defective for growth? Could it be required for cell division as perhaps suggested by the observations described in the last paragraph of the subsection "Localization of SecA and SpA precursors in staphylococci"?.

Please read our first response above.

> Reviewer \#3:
>
> \[...\] While the cumulative data in the paper support the title that SpA septal secretion requires SecA, there are numerous instances earlier in the paper, before the key data to support this are shown (in Figure 8) where statements to this effect are made. For example, the first section title indicates SpA signal peptide variants are defective for septal secretion when the data presented in this section only support a general secretion phenotype. There are other premature examples of this and I found it confusing and later misleading. I suggest this be modified throughout the manuscript.

We appreciate the reviewers concerns and have modified the manuscript accordingly.

> The crosslinking and pulldown experiments used a mutant SpA precursor that appears to accumulate at higher levels than WT in general, and accumulates at the septum. While (I think) I understand the rationale for using this construct for pulldowns (they are enriched at the septum so interactions are more likely), I wonder if it could lead to \'forced\' interactions and/or miss other interactions with wild type SpAED. Did the authors also try using SpAED? What happened? Can these interactions be validated in the absence of crosslinks (either for the mutant or WT signal sequence) by bacterial two hybrid or another method, to confirm if they are direct or indirect interactions? And why were SecA, SecDF, and LtaS singled out for further analysis?

The reviewer raised two excellent points. First, is it possible to capture physiological interactions between a substrate (here the secretion substrate, i.e. YSIRK-GXXS signal peptide bearing precursor) and a catalyst (here the translocation machinery, minimally composed of SecA and SecYEG)? We presume most enzymologists would answer such query with "depends on the rate of catalysis". Translocation, similar to translation, is thought to be fast: it takes seconds to translocate a precursor several hundred residues in length. One might therefore presume that the answer to such query is "no". This did not prevent us from trying. Using affinity chromatography of wild-type SpA~ED~ solubilized from membranes to enrich for precursors in cells with or without crosslinker and analyzing eluates by immunoblotting for the presence of SpA~ED~ and SecA, identified the former but not the latter (see revised Figure 4).

Second, can one study a model substrate (precursor) that gets stuck in the membrane? Beckwith and colleagues studied MalE precursor fused β-galactosidase and demonstrated that the hybrid, once initiated into the Sec pathway, got stuck in the membrane, blocking the secretion of other precursors. The Beckwith lab used MalE-LacZ toxicity for genetic analyses of the secretory pathway; we suppose they could have also used a biochemical approach to isolate secretion machinery components alongside the arrested substrate. This was the experimental approach by Gottfried Schatz and colleagues, utilizing an impassable substrate (DHFR hybrids) to isolate components of the mitochondrial protein import machinery.

We elected for a different experimental path: isolating signal peptide mutants that are defective for precursor secretion. Emr and Silhavy used this approach to identify mutations in the coding sequence for the signal peptide of *E. coli lamB*; LamB is an outer membrane porin responsible for diffusion of maltodextrins into the bacterial periplasm. Similar to Silhavy and colleagues, we identified point mutants in the signal peptide of SpA~ED~ that were arrested in secretion. As we cannot apply selection to isolate genetic suppressors in *S. aureus*, we used the biochemical approach of Schatz and colleagues to isolate secretion machinery components that co-purified with the SpA~ED/S18L~ precursor. Of course, the reviewer is correct with his inquiry that interactions with the mutant signal peptide should be stable, i.e. they should not require a crosslinking reagent. To test this, we performed the affinity chromatography experiment with and without crosslinker. Following affinity chromatography of SpA~ED/S18L~ precursor and analysis of eluates via immunoblotting, we observed in the revised Figure 4 that SecA co-purifies with SpA~ED/S18L~ both in the presence and in the absence of the crosslinking agent.

Why were only SecA, SecDF and LtaS chosen for further analysis? We analyzed the mass spectrometry data for candidates that we presumed were likely to be involved in the secretion of SpA~ED~ either because they are known components of the protein secretion pathway (SecA/YEG/DF) or because they are located within septal membranes. In addition to LtaS, we analyzed also EzrA, PBP2, ClpB, ClpC, SAOUHSC_01854 (unknown function), SAOUHSC_02423 (UDP-N-acetylglucosamine pyrophosphorylase), SAOUHSC_01583 (conserved hypothetical phage protein), PurL, ClpB, PknB (serine/threonine protein kinase), RseB, and SAOUHSC_02406. However, in addition to *secA* and *secDF*, the *ltaS* depletion strain was the only mutant strain that exhibited a phenotype in septal secretion of SecA. We added a supplementary figure (Figure 4---figure supplement 1) and edited the text to illustrate our experimental plans and reasoning.

We did not use bacterial two hybrid studies to ask whether or not there are direct interactions between SpA~ED/S18L~ precursor and SecA, SecDF or LtaS. SecA is known to bind to the signal peptides of precursor proteins; this will likely include the SpA precursor. SecDF acts on unfolded polypeptides emerging from the secretory pathway (SecYEG), not on folded proteins purified by affinity chromatography. Our mass spectrometry analysis detected small amounts of SecDF, likely because SpA~ED/S18L~ associates not only with SecA but also with SecYEG/DF. We presume that LtaS does not directly interact with SpA~ED/S18L~. SpA~ED/S18L~ complexed with SecA may associate with LtaS following DDM solubilization of septal membranes. We modified the manuscript to make these points clear.

> I am puzzled by the data presented in Figure 7 and 8: on one hand, SecA is everywhere (Figure 7), but upon depletion (albeit the conditions used here are unclear) SpA becomes diffuse (presumably in the membrane?) (Figure 8). Since the cells don\'t look sick (as in Figure 6D), this must be a mild SecA depletion. So the residual SecA is presumably everywhere in the membrane, but is not interacting with SpA at the septum? Why not? What provides the specificity for this localized interaction? Why does YSIRK/GXXS interact with only a subset of SecA molecules at the septum when SecA is everywhere? This key question remains unclear to me.

On the SecA observations, as is discussed in our first response to reviewer \#2, SecA function is required for *E. coli* or *S. aureus* growth, but not SecA protein. Thus, after 3 hours of depletion, SecA is no longer detected yet SecA-depleted cells have not yet ceased growth. Nevertheless, SecA activity is diminished after 3 hours of depletion. After 6 hours of SecA-depletion, as secreted products are being degraded and cannot be replenished, *S. aureus* WY223 ceases growth, cells become bloated and eventually die. We show that in *S. aureus*, SecA associates with all membranes, i.e. SecA-GFP is not restricted to septal membranes, as microscopic localization studies reveal the presence of the protein in the vicinity of all membranes. However, Figure 8 shows that SpA, which requires SecA for secretion, can only be secreted at septal membranes by cells with active SecA. We infer from these data that SpA precursor (SpA~ED/S18L~) associates with SecA, however SecA-SpA complexes are only translocated at septal membranes, presumably because these membranes harbor a protease that removes the YSIRK-GXXS peptide, thereby allowing processed SpA to advance along the secretory pathway. What chemical feature defines septal membranes? We propose the production of lipoteichoic acid is the key chemical feature marking septal membranes for YSIRK/GXXS precursor translocation. In the absence of SecA, SpA precursors associate with all membranes, however they cannot traffic to septal membranes and be translocated at this site because they cannot enter the secretory pathway.
